Group 1 - ASE Technology Holding Co., Ltd. (ASX) provides semiconductor packaging and testing, and electronic manufacturing services, with a current year earnings estimate revised downward by 6.2% over the last 60 days [1] - Acadia Healthcare Company, Inc. (ACHC) is a provider of behavioral healthcare services, with a current year earnings estimate revised downward by 18.1% over the last 60 days [2] - Blackbaud, Inc. (BLKB) offers cloud software solutions to educational institutions, with a current year earnings estimate revised downward by 6.7% over the last 60 days [2]

Group 1 - ASE Technology Holding Co., Ltd. (ASX) is a semiconductor packaging and testing company with a Zacks Consensus Estimate for its current year earnings revised 6.2% downward over the last 60 days [1] - Acadia Healthcare Company, Inc. (ACHC) is a provider of behavioral healthcare services, and its Zacks Consensus Estimate for current year earnings has been revised 18.8% downward over the last 60 days [1] - Barrick Gold Corporation (GOLD) is a global explorer, developer, producer, and seller of gold and copper properties, with its Zacks Consensus Estimate for current year earnings revised 16.6% downward over the last 60 days [2]

Financial Data and Key Metrics Changes - Total revenue for Q4 2024 increased by 4.2% year-over-year to $774 million, with full-year revenue exceeding $3.1 billion, marking a 7.7% increase over 2023 [8][21] - Same facility patient days grew by 3.2% in Q4, remaining stable between 3% and 4% throughout the quarter [8][21] - Adjusted EBITDA for Q4 2024 was $153.1 million, with an adjusted EBITDA margin of 19.8%, down from 22.8% in the same quarter last year [22][23] - Adjusted income attributable to Acadia stockholders per diluted share was $0.64 for Q4 2024, compared to $0.85 for the prior year period [25] Business Line Data and Key Metrics Changes - Same facility revenue grew by 4.7% compared to Q4 2023, driven by patient day growth and a 1.4% increase in revenue per patient day [21] - Startup losses related to new facilities were $11.2 million in Q4 2024, a $6 million year-over-year increase [23] Market Data and Key Metrics Changes - The company reported a more stable labor environment in 2024, which supported recruitment and retention initiatives [9] - The company anticipates adding between 800 and 1,000 total beds in 2025, continuing to address the mental health and addiction crisis in the U.S. [18][19] Company Strategy and Development Direction - The company is focused on transforming patient care and has invested heavily in technology to enhance safety and care delivery [11][12] - Acadia's growth strategy includes completing construction on approximately 1,300 beds in 2024, with 776 of these beds becoming operational [15][17] - The company aims to maintain a balanced approach to growth and free cash flow generation, expecting to return to free cash flow positive by the end of 2026 [42][43] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's strategy and goals, emphasizing the importance of expanding access to specialized care [19] - The outlook for 2025 includes revenue guidance of $3.3 billion to $3.4 billion and adjusted EBITDA guidance of $675 million to $725 million [27][28] - Management acknowledged challenges from underperforming facilities but maintained a cautious approach to guidance [29][30] Other Important Information - The company has authorized a new $300 million share repurchase program, which will be executed based on market conditions [44] - The company expects capital spending in the range of $630 million to $690 million for 2025, with a significant portion allocated to expansion spending [28] Q&A Session Summary Question: Can you provide insights on financing plans and cash flow expectations? - Management confirmed refinancing existing bank facilities and upsizing to about a billion dollars, with expectations of returning to cash flow positive by the end of 2026 [47][48] Question: How do you view the growth outlook and margin assumptions post-2025? - Management expects revenue growth of 7% to 9% and EBITDA growth of 8% to 10% in the years following 2025, with a focus on balancing capital expenditures and free cash flow [62][66] Question: What is the current status of referral activity and its impact on growth? - Management reported that referral issues are less of a challenge now, with ongoing efforts to improve relationships with key referral sources [99][102] Question: What actions are being taken to improve underperforming facilities? - Management is conducting comprehensive reviews of underperforming facilities, focusing on business development, leadership, and technology adoption [118][122]

Core Viewpoint - Acadia Healthcare Company, Inc. reported weaker-than-expected fourth-quarter earnings, with adjusted EPS of 64 cents, missing the Zacks Consensus Estimate by 11.1% and declining 24.7% year over year [1][2] Financial Performance - Total revenues for the fourth quarter increased by 4.2% year over year to $774.2 million, but fell short of consensus estimates [2] - Same-facility revenues reached $765 million, a 4.7% year-over-year increase, but also missed the estimate of $796.7 million [4] - Adjusted EBITDA decreased by 9.7% year over year to $153.1 million, below the estimate of $179.2 million, with a margin decline of 300 basis points to 19.8% [5] Operational Metrics - Patient days improved by 2.5% year over year, while admissions grew by 2.9% [5] - Revenue per patient day increased by 1.7% year over year, lower than the growth estimate of 3.7% [5] - The average length of stay declined by 0.4% year over year, missing the growth estimate of 2.5% [5] Expense Overview - Total expenses rose by 11.1% year over year to $736.2 million, exceeding the estimate of $703.3 million, driven by higher salaries, wages, benefits, and operating expenses [6] Balance Sheet and Cash Flow - As of December 31, 2024, cash and cash equivalents were $76.3 million, down 23.8% from the previous year [7] - Total assets increased by 9.5% to $6 billion, while long-term debt rose by 11.2% to $1.9 billion [8] - Net cash provided by operations totaled $129.7 million, significantly lower than $462.3 million in the prior year [8] Full Year Update - For the full year 2024, revenues rose by 7.7%, while adjusted EPS declined by 5.4% to $3.30 [9] Guidance for 2025 - Projected revenues for the first quarter of 2025 are between $765 million and $775 million, with adjusted EBITDA estimated at $130-$135 million [10] - Full-year 2025 revenue guidance is between $3.3 billion and $3.4 billion, indicating a 6.2% improvement from 2024 [10] - Adjusted EPS is expected to be between $2.50 and $2.80 [11]

Core Viewpoint - Acadia Healthcare Company, Inc. is expected to report its fourth-quarter 2024 results on February 27, 2025, with earnings estimated at 72 cents per share and revenues of $779.89 million, indicating a year-over-year revenue growth of 5% despite a decline in earnings per share [1][2]. Financial Estimates - The fourth-quarter earnings estimate has decreased by 2 cents per share over the past 60 days, reflecting a year-over-year decrease of 15.3% in earnings [2]. - For the full year 2024, the revenue estimate for Acadia Healthcare is $3.16 billion, representing a year-over-year increase of 7.9%, while the EPS estimate is $3.38, indicating a decline of approximately 1.7% year-over-year [3]. Recent Performance - Acadia Healthcare has consistently beaten consensus earnings estimates in the last four quarters, with an average surprise of 3.9% [3]. - However, the current model indicates uncertainty regarding an earnings beat for the upcoming quarter, as the company has an Earnings ESP of -5.44% and a Zacks Rank of 4 (Sell) [4]. Revenue Drivers - Revenue estimates for Acute Inpatient Psychiatric Facilities are projected to increase nearly 6% from the previous year's figure of $375.6 million, while Residential Treatment Centers are expected to see a 23% increase from $84.3 million [6]. - U.S. same-facility patient days are anticipated to grow by 4% year-over-year, with admissions expected to rise by 3.1% [7]. Expense Considerations - Rising expenses are likely to impact profit levels, with total expenses expected to increase by more than 6% in the upcoming quarter due to higher salaries, professional fees, and operating costs [8]. - Supply costs are also projected to rise due to increased utilization [8]. Other Revenue Insights - Revenue estimates for Specialty Treatment Facilities are expected to decrease by nearly 2% from $151.3 million, and Comprehensive Treatment Centers are projected to see a 1.2% decline from $131.6 million [9].